The University of Maryland has a history of collaborating with industry to support research that enters the university`s missions in teaching, research, and public service. Cooperative efforts are encouraged because they bring both mutual benefits and benefits to society. Support for industry contributes to the training of scientists, engineers and others, as well as to the development of technologies that can be put into practice by society. Facilitating technology transfer is an important objective of the cooperative industrial-university relationship. This agreement entrusts a research partner with a specific set of work as part of a research project (or a number of research projects) owned by the university and normally involves payments to the partner. The agreement is often concluded as a result of a main grant or other research funding agreement and includes discrete and specific work carried out by a partner organisation. The university remains responsible for the main award, but it often ends up in the conditions relevant to the research partner and, as such, these are reflected in the sub-agreement. The Lambert toolkit, including guides and model agreements, is only designed to be used if the agreements are governed by English law. To use another legal system, you must use legal advice from a qualified lawyer to deliberate on the law of that country.
There are several different model conventions and you should use the one that best suits your type of study and sponsorship agreements. For more information, visit the IRAS website. The collegial environment and the efficient direction of the department within the UM guarantee the highest standards of performance in all research projects. University health and safety guidelines (e.g. B vulnerable persons, biosecurity, labour and environmental protection and animal welfare) apply to all research conducted at the university. Projects are also implemented in accordance with the principles of equal opportunities and positive action. The university has strong financial management programs that ensure careful control and accountability of all expenditures. UK-China collaborative research IP Toolkit information and link added. The Clinical Trial Agreement model for primary care research (Primary Care mCTA) sponsored by the biopharmaceutical industry has been developed and approved by the Association of the British Pharmaceutical Industry, the BioIndustry Association, a number of very active GPs, the British Medical Association, the Medical Protection Society and the UK Health Services. The Health Research Authority (HRA) supports the use of model agreements. We worked with the Korean IPO to develop a new toolkit that helps UK and Korean universities and industry manage ip through joint research projects.
The aim of the toolkit is to help non-IP experts to quickly and easily resolve issues related to the ownership and exploitation of IP rights generated by cooperations. In cases where common inventiveness results from cooperation agreements with industrial sponsors, the terms of common ownership shall, where appropriate, be negotiated. . . .